Type 1 Diabetes and Obstructive Sleep Apnea
Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18-50
SponsorUniversity of Chicago
About this trial
The purpose of the study is to investigate the role of sleep apnea in glycemic dysregulation in adults with Type 1 diabetes.
Eligibility criteria
Qualifiers
Age: 18 to 50 years old
Type 1 Diabetes on insulin pump therapy and using a CGM device with an GMI (glucose management indicator) between 5.5 and 8.5% with hemoglobin in the normal range at screening
OSA by home sleep apnea test
Disqualifiers
Regular and adherent CPAP use per clinical guidelines
Requiring oxygen or advanced positive airway pressure modalities during sleep
Having a 'fall-asleep' or 'near miss' accident in the past 6-months
Shift work
Trial design
Treatments tested in this trial
- Continuous positive airway pressure (CPAP)
Treatment groups
40 Participants
are divided into 2 treatment groupsSponsors and collaborators
University of Chicago
Lead sponsor
National Heart, Lung, and Blood Institute (NHLBI)
Collaborator
Source ClinicalTrials.gov